Hostname: page-component-7bb8b95d7b-l4ctd Total loading time: 0 Render date: 2024-09-20T01:07:30.787Z Has data issue: false hasContentIssue false
  • English
  • Français

Administración nasogástrica de risperidona para tratar las ideas delirantes de envenenamiento

Published online by Cambridge University Press:  12 May 2020

Jawaid A. Khan  and
Beryl Langley
Jawaid A. Khan
Affiliation:
Hospital Edith Cavell, Breton Gate, Peterborough PE3 6GZ, Reino Unido
Beryl Langley
Affiliation:
Hospital Edith Cavell, Breton Gate, Peterborough PE3 6GZ, Reino Unido

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Cartas al director
Information
European Psychiatry (Ed. Española) , Volume 11 , Issue 7 , October 2004 , pp. 460 - 461
Copyright
Copyright © European Psychiatric Association 2004

References

Bibliografía

Degenhardt, L, Hall, W. Cannabis and psychosis. Curr Psychiatry Rep 2002;4:191–6.CrossRefGoogle ScholarPubMed
Glass, M. The role of cannabinoids in neurodegenerativo diseases. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:743–65.CrossRefGoogle Scholar
Hambrecht, M, Hafner, H. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Aust NZ J Psychiatry 2000;34:468–75.CrossRefGoogle Scholar
Robinson, S, Winnik, HZ. Severe psychotic disturbances following crasch diet weight loss. Arch Gen Psychiatry 1973;29:559–62.CrossRefGoogle Scholar
Skosnik, PD, Sparz-Glenn, L, Park, S. Cannabis use is associated with schizotypy and attentional dysinhibition. Schizophrenia Res 2001;25:743–65.Google Scholar